The former interpretation is supported by the current study and other work showing a protective role for VEGF in the bleomycin model (26), whereas the latter interpretation is supported by studies demonstrating epithelium and endothelium (both of which are obliterated by fibrosis) to be a dominant source of VEGF in the lungs of patients with IPF (20). The gene discussed is VEGFA; the disease is fibrosis.